|
1
|
Maron BJ, Towbin JA, Thiene G,
Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE and Young
JB: Contemporary definitions and classification of the
cardiomyopathies: an American Heart Association Scientific
Statement from the Council on Clinical Cardiology, Heart Failure
and Transplantation Committee; Quality of Care and Outcomes
Research and Functional Genomics and Translational Biology
Interdisciplinary Working Groups; and Council on Epidemiology and
Prevention. Circulation. 113:1807–1816. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdo AS, Kemp R, Barham J and Geraci SA:
Dilated cardiomyopathy and role of antithrombotic therapy. Am J Med
Sci. 339:557–560. 2010.PubMed/NCBI
|
|
3
|
Aleksova A, Carriere C, Zecchin M, Barbati
G, Vitrella G, Di Lenarda A and Sinagra G: New-onset left bundle
branch block independently predicts long-term mortality in patients
with idiopathic dilated cardiomyopathy: data from the Trieste Heart
Muscle Disease Registry. Europace. 16:1450–1459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Disertori M, Quintarelli S, Mazzola S,
Favalli V, Narula N and Arbustini E: The need to modify patient
selection to improve the benefits of implantable
cardioverter-defibrillator for primary prevention of sudden death
in non-ischaemic dilated cardiomyopathy. Europace. 15:1693–1701.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koutalas E, Kanoupakis E and Vardas P:
Sudden cardiac death in non-ischemic dilated cardiomyopathy: a
critical appraisal of existing and potential risk stratification
tools. Int J Cardiol. 167:335–341. 2013. View Article : Google Scholar
|
|
6
|
Gaaloul I, Riabi S, Harrath R, Hunter T,
Hamda KB, Ghzala AB, Huber S and Aouni M: Coxsackievirus B
detection in cases of myocarditis, myopericarditis, pericarditis
and dilated cardiomyopathy in hospitalized patients. Mol Med Rep.
10:2811–2818. 2014.PubMed/NCBI
|
|
7
|
Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL,
Li BX, Shen YW, Tao LY and Zhao ZQ: MicroRNA-21 regulation of the
progression of viral myocarditis to dilated cardiomyopathy. Mol Med
Rep. 10:161–168. 2014.PubMed/NCBI
|
|
8
|
Kong Q, Li X, Wu W, Yang F, Liu Y, Lai W,
Pan X, Gao M and Xue Y: Increased circulating T-helper 22 cells in
patients with dilated cardiomyopathy. Mol Med Rep. 10:359–364.
2014.PubMed/NCBI
|
|
9
|
Yoshikawa T: Contribution of acquired
factors to the pathogenesis of dilated cardiomyopathy. -The cause
of dilated cardiomyopathy: genetic or acquired? (Acquired-Side).
Circ J. 75:1766–1773. 2011. View Article : Google Scholar
|
|
10
|
McNally EM, Golbus JR and Puckelwartz MJ:
Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin
Invest. 123:19–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wahbi K, Béhin A, Bécane HM, Leturcq F,
Cossée M, Laforêt P, Stojkovic T, Carlier P, Toussaint M, Gaxotte
V, Cluzel P, Eymard B and Duboc D: Dilated cardiomyopathy in
patients with mutations in anoctamin 5. Int J Cardiol. 168:76–79.
2013. View Article : Google Scholar
|
|
12
|
Ruppert V, Meyer T, Richter A, Maisch B
and Pankuweit S: German Competence Network of Heart F:
Identification of a missense mutation in the melusin-encoding
ITGB1BP2 gene in a patient with dilated cardiomyopathy. Gene.
512:206–210. 2013. View Article : Google Scholar
|
|
13
|
Pankuweit S1, Ruppert V, Jónsdóttir T,
Müller HH and Meyer T: German Competence Network of Heart Failure:
The HLA class II allele DQB1 0309 is associated with dilated
cardiomyopathy. Gene. 531:180–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Agrawal PB, Pierson CR, Joshi M, Liu X,
Ravenscroft G, Moghadaszadeh B, Talabere T, Viola M, Swanson LC,
Haliloğlu G, Talim B, Yau KS, Allcock RJ, Laing NG, Perrella MA and
Beggs AH: SPEG interacts with myotubularin, and its deficiency
causes centronuclear myopathy with dilated cardiomyopathy. Am J Hum
Genet. 95:218–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matsa LS, Sagurthi SR, Ananthapur V, Nalla
S and Nallari P: Endothelin 1 gene as a modifier in dilated
cardiomyopathy. Gene. 548:256–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Costa MW, Guo G, Wolstein O, Vale M,
Castro ML, Wang L, Otway R, Riek P, Cochrane N, Furtado M,
Semsarian C, Weintraub RG, Yeoh T, Hayward C, Keogh A, Macdonald P,
Feneley M, Graham RM, Seidman JG, Seidman CE, Rosenthal N, Fatkin D
and Harvey RP: Functional characterization of a novel mutation in
NKX2-5 associated with congenital heart disease and adult-onset
cardiomyopathy. Circ Cardiovasc Genet. 6:238–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li RG, Li L, Qiu XB, Yuan F, Xu L, Li X,
Xu YJ, Jiang WF, Jiang JQ, Liu X, Fang WY, Zhang M, Peng LY, Qu XK
and Yang YQ: GATA4 loss-of-function mutation underlies familial
dilated cardiomyopathy. Biochem Biophys Res Commun. 439:591–596.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao L, Xu JH, Xu WJ, Yu H, Wang Q, Zheng
HZ, Jiang WF, Jiang JF and Yang YQ: A novel GATA4 loss-of-function
mutation responsible for familial dilated cardiomyopathy. Int J Mol
Med. 33:654–660. 2014.
|
|
19
|
Li J, Liu WD, Yang ZL, Yuan F, Xu L, Li RG
and Yang YQ: Prevalence and spectrum of GATA4 mutations associated
with sporadic dilated cardiomyopathy. Gene. 548:174–181. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu L, Zhao L, Yuan F, Jiang WF, Liu H, Li
RG, Xu YJ, Zhang M, Fang WY, Qu XK, Yang YQ and Qiu XB: GATA6
loss-of-function mutations contribute to familial dilated
cardiomyopathy. Int J Mol Med. 34:1315–1322. 2014.PubMed/NCBI
|
|
21
|
Dhandapany PS, Razzaque MA, Muthusami U,
Kunnoth S, Edwards JJ, Mulero-Navarro S, Riess I, Pardo S, Sheng J,
Rani DS, Rani B, Govindaraj P, Flex E, Yokota T, Furutani M,
Nishizawa T, Nakanishi T, Robbins J, Limongelli G, Hajjar RJ,
Lebeche D, Bahl A, Khullar M, Rathinavel A, Sadler KC, Tartaglia M,
Matsuoka R, Thangaraj K and Gelb BD: RAF1 mutations in
childhood-onset dilated cardiomyopathy. Nat Genet. 46:635–639.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roh JI, Cheong C, Sung YH, Lee J, Oh J,
Lee BS, Lee JE, Gho YS, Kim DK, Park CB, Lee JH, Lee JW, Kang SM
and Lee HW: Perturbation of NCOA6 leads to dilated cardiomyopathy.
Cell Rep. 8:991–998. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Flack E and Kannankeril PJ: The genetics
of dilated cardiomyopathy. Heart Rhythm. 9:397–398. 2012.
View Article : Google Scholar
|
|
24
|
Pikkarainen S, Tokola H, Kerkelä R and
Ruskoaho H: GATA transcription factors in the developing and adult
heart. Cardiovasc Res. 63:196–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oka T, Xu J and Molkentin JD:
Re-employment of developmental transcription factors in adult heart
disease. Semin Cell Dev Biol. 18:117–131. 2007. View Article : Google Scholar
|
|
26
|
Kikuchi K, Holdway JE, Werdich AA,
Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae CA, Stainier DY
and Poss KD: Primary contribution to zebrafish heart regeneration
by gata4(+) cardiomyocytes. Nature. 464:601–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akazawa H and Komuro I: Cardiac
transcription factor Csx/Nkx2-5: Its role in cardiac development
and diseases. Pharmacol Ther. 107:252–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kasahara A, Cipolat S and Chen Y:
Mitochondrial fusion directs cardiomyocyte differentiation via
calcineurin and Notch signaling. Science. 342:734–737. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai H, Katoh-Kurasawa M, Muramoto T,
Santhanam B, Long Y, Li L, Ueda M, Iglesias PA, Shaulsky G and
Devreotes PN: Nucleocytoplasmic shuttling of a GATA transcription
factor functions as a development timer. Science. 343:12495312014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC and Srivastava D:
GATA4 mutations cause human congenital heart defects and reveal an
interaction with TBX5. Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rajagopal SK, Ma Q, Obler D, Shen J,
Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V,
Srivastava D, Goldmuntz E, Broman KW, Benson DW, Smoot LB and Pu
WT: Spectrum of heart disease associated with murine and human
GATA4 mutation. J Mol Cell Cardiol. 43:677–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang YQ, Li L, Wang J, Liu XY, Chen XZ,
Zhang W, Wang XZ, Jiang JQ, Liu X and Fang WY: A novel GATA4
loss-of-function mutation associated with congenital ventricular
septal defect. Pediatr Cardiol. 33:539–546. 2012. View Article : Google Scholar
|
|
33
|
Wang J, Sun YM and Yang YQ: Mutation
spectrum of the GATA4 gene in patients with idiopathic atrial
fibrillation. Mol Biol Rep. 39:8127–8135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang YQ, Wang J, Liu XY, Chen XZ, Zhang W
and Wang XZ: Mutation spectrum of GATA4 associated with congenital
atrial septal defects. Arch Med Sci. 9:976–983. 2013. View Article : Google Scholar
|
|
35
|
Yang YQ, Gharibeh L, Li RG, Xin YF, Wang
J, Liu ZM, Qiu XB, Xu YJ, Xu L, Qu XK, Liu X, Fang WY, Huang RT,
Xue S and Nemer G: GATA4 loss-of-function mutations underlie
familial tetralogy of fallot. Hum Mutat. 34:1662–1671. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang E, Sun S, Qiao B, Duan W, Huang G, An
Y, Xu S, Zheng Y, Su Z, Gu X, Jin L and Wang H: Identification of
functional mutations in GATA4 in patients with congenital heart
disease. PLoS One. 8:e621382013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiang R, Fan LL, Huang H, Cao BB, Li XP,
Peng DQ and Xia K: A novel mutation of GATA4 (K319E) is responsible
for familial atrial septal defect and pulmonary valve stenosis.
Gene. 534:320–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Posch MG, Boldt LH, Polotzki M, Richter S,
Rolf S, Perrot A, Dietz R, Ozcelik C and Haverkamp W: Mutations in
the cardiac transcription factor GATA4 in patients with lone atrial
fibrillation. Eur J Med Genet. 53:201–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang JQ, Shen FF, Fang WY, Liu X and Yang
YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol
Med. 28:1025–1032. 2011.PubMed/NCBI
|
|
40
|
Jiang JQ, Li RG, Wang J, Liu XY, Xu YJ,
Fang WY, Chen XZ, Zhang W, Wang XZ and Yang YQ: Prevalence and
spectrum of GATA5 mutations associated with congenital heart
disease. Int J Cardiol. 165:570–573. 2013. View Article : Google Scholar
|
|
41
|
Wei D, Bao H, Zhou N, Zheng GF, Liu XY and
Yang YQ: GATA5 loss-of-function mutation responsible for the
congenital ventriculoseptal defect. Pediatr Cardiol. 34:504–511.
2013. View Article : Google Scholar
|
|
42
|
Wei D, Bao H, Liu XY, Zhou N, Wang Q, Li
RG, Xu YJ and Yang YQ: GATA5 loss-of-function mutations underlie
tetralogy of fallot. Int J Med Sci. 10:34–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: Somatic GATA5 mutations in sporadic tetralogy of Fallot. Int J
Mol Med. 33:1227–1235. 2014.PubMed/NCBI
|
|
44
|
Shi LM, Tao JW, Qiu XB, Wang J, Yuan F, Xu
L, Liu H, Li RG, Xu YJ, Wang Q, Zheng HZ, Li X, Wang XZ, Zhang M,
Qu XK and Yang YQ: GATA5 loss-of-function mutations associated with
congenital bicuspid aortic valve. Int J Mol Med. 33:1219–1226.
2014.PubMed/NCBI
|
|
45
|
Yang YQ, Wang J, Wang XH, Wang Q, Tan HW,
Zhang M, Shen FF, Jiang JQ, Fang WY and Liu X: Mutational spectrum
of the GATA5 gene associated with familial atrial fibrillation. Int
J Cardiol. 157:305–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.
|
|
47
|
Kodo K, Nishizawa T, Furutani M, Arai S,
Yamamura E, Joo K, Takahashi T, Matsuoka R and Yamagishi H: GATA6
mutations cause human cardiac outflow tract defects by disrupting
semaphorin-plexin signaling. Proc Natl Acad Sci USA.
106:13933–13938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin X, Huo Z, Liu X, Zhang Y, Li L, Zhao
H, Yan B, Liu Y, Yang Y and Chen YH: A novel GATA6 mutation in
patients with tetralogy of Fallot or atrial septal defect. J Hum
Genet. 55:662–667. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zheng GF, Wei D, Zhao H, Zhou N, Yang YQ
and Liu XY: A novel GATA6 mutation associated with congenital
ventricular septal defect. Int J Mol Med. 29:1065–1071.
2012.PubMed/NCBI
|
|
50
|
Wang J, Luo XJ, Xin YF, Liu Y, Liu ZM,
Wang Q, Li RG, Fang WY, Wang XZ and Yang YQ: Novel GATA6 mutations
associated with congenital ventricular septal defect or tetralogy
of fallot. DNA Cell Biol. 31:1610–1617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Huang RT, Xue S, Xu YJ and Yang YQ:
Somatic mutations in the GATA6 gene underlie sporadic tetralogy of
Fallot. Int J Mol Med. 31:51–58. 2013.
|
|
52
|
Wang X, Ji W, Wang J, Zhao P, Guo Y, Xu R,
Chen S and Sun K: Identification of two novel GATA6 mutations in
patients with nonsyndromic conotruncal heart defects. Mol Med Rep.
10:743–748. 2014.PubMed/NCBI
|
|
53
|
Yang YQ, Wang XH, Tan HW, Jiang WF, Fang
WY and Liu X: Prevalence and spectrum of GATA6 mutations associated
with familial atrial fibrillation. Int J Cardiol. 155:494–496.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang YQ, Li L, Wang J, Zhang XL, Li RG, Xu
YJ, Tan HW, Wang XH, Jiang JQ, Fang WY and Liu X: GATA6
loss-of-function mutation in atrial fibrillation. Eur J Med Genet.
55:520–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li J, Liu WD, Yang ZL and Yang YQ: Novel
GATA6 loss-of-function mutation responsible for familial atrial
fibrillation. Int J Mol Med. 30:783–790. 2012.PubMed/NCBI
|
|
56
|
Moak JP, Maron BJ, Seidman CE and Seidman
JG: Congenital heart disease caused by mutations in the
transcription factor NKX2-5. Science. 281:108–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Guntheroth W, Chun L, Patton KK,
Matsushita MM, Page RL and Raskind WH: Wenckebach periodicity at
rest that normalizes with tachycardia in a family with a NKX2.5
mutation. Am J Cardiol. 110:1646–1650. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Perera JL, Johnson NM, Judge DP and
Crosson JE: Novel and highly lethal NKX2.5 missense mutation in a
family with sudden death and ventricular arrhythmia. Pediatr
Cardiol. 35:1206–1212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Izumi K, Noon S, Wilkens A and Krantz ID:
NKX2.5 mutation identification on exome sequencing in a patient
with heterotaxy. Eur J Med Genet. 57:558–561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Qu XK, Qiu XB, Yuan F, Wang J, Zhao CM,
Liu XY, Zhang XL, Li RG, Xu YJ, Hou XM, Fang WY, Liu X and Yang YQ:
A novel NKX2.5 loss-of-function mutation associated with congenital
bicuspid aortic valve. Am J Cardiol. 114:1891–1895. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang
WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations
associated with idiopathic atrial fibrillation. Clinics (Sao
Paulo). 68:777–784. 2013. View Article : Google Scholar
|
|
62
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: A novel NKX2.5 loss-of-function mutation responsible for
familial atrial fibrillation. Int J Mol Med. 31:1119–1126.
2013.PubMed/NCBI
|
|
63
|
Yu H, Xu JH, Song HM, Zhao L, Xu WJ, Wang
J, Li RG, Xu L, Jiang WF, Qiu XB, Jiang JQ, Qu XK, Liu X, Fang WY,
Jiang JF and Yang YQ: Mutational spectrum of the NKX2-5 gene in
patients with lone atrial fibrillation. Int J Med Sci. 11:554–563.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
McCulley DJ and Black BL: Transcription
factor pathways and congenital heart disease. Curr Top Dev Biol.
100:253–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Laforest B and Nemer M: GATA5 interacts
with GATA4 and GATA6 in outflow tract development. Dev Biol.
358:368–378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Singh MK, Li Y, Li S, Cobb RM, Zhou D, Lu
MM, Epstein JA, Morrisey EE and Gruber PJ: Gata4 and Gata5
cooperatively regulate cardiac myocyte proliferation in mice. J
Biol Chem. 285:1765–1772. 2010. View Article : Google Scholar :
|
|
67
|
Haworth KE, Kotecha S, Mohun TJ and
Latinkic BV: GATA4 and GATA5 are essential for heart and liver
development in Xenopus embryos. BMC Dev Biol. 8:742008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Holtzinger A and Evans T: Gata5 and Gata6
are functionally redundant in zebrafish for specification of
cardiomyocytes. Dev Biol. 312:613–622. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Elliott P, O’Mahony C, Syrris P, Evans A,
Rivera Sorensen C, Sheppard MN, Carr-White G, Pantazis A and
McKenna WJ: Prevalence of desmosomal protein gene mutations in
patients with dilated cardiomyopathy. Circ Cardiovasc Genet.
3:314–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Molkentin JD: The zinc finger-containing
transcription factors GATA-4, -5, and -6. Ubiquitously expressed
regulators of tissue-specific gene expression. J Biol Chem.
275:38949–38952. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Nemer G, Qureshi ST, Malo D and Nemer M:
Functional analysis and chromosomal mapping of Gata5, a gene
encoding a zinc finger DNA-binding protein. Mamm Genome.
10:993–999. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
McBride K and Nemer M: Regulation of the
ANF and BNP promoters by GATA factors: lessons learned for cardiac
transcription. Can J Physiol Pharmacol. 79:673–681. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Jia H, King IN, Chopra SS, Wan H, Ni TT,
Jiang C, Guan X, Wells S, Srivastava D and Zhong TP: Vertebrate
heart growth is regulated by functional antagonism between Gridlock
and Gata5. Proc Natl Acad Sci USA. 104:14008–14013. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Laforest B, Andelfinger G and Nemer M:
Loss of Gata5 in mice leads to bicuspid aortic valve. J Clin
Invest. 121:2876–2887. 2011. View Article : Google Scholar : PubMed/NCBI
|
